Background: Ciliary membrane cholesterol and protein localization

Primary cilia on the cell surface detect external physical and chemical stimuli and relay signals into the cell. The polycystic kidney disease-associated PKD2 variant p.L517R has been reported to show reduced ciliary localization despite normal ion-channel activity. This review, published in Nihon Yakurigaku Zasshi, summarizes these earlier findings and presents ciliary membrane cholesterol as a potential therapeutic target.

The ciliary membrane is rich in cholesterol, which is essential for the physiological functions of ciliary proteins such as G protein-coupled receptors (GPCRs) and ion channels. Ciliary dysfunction is associated with ciliopathies, including polycystic kidney disease and retinal degeneration. This does not mean that cholesterol deficiency alone can explain all these disorders.

In earlier work, the researchers identified a pathway in which some peroxisomes, intracellular organelles, move along microtubules to the ciliary base and supply cholesterol to the ciliary membrane. The review also describes findings that ciliary localization of the polycystin complex (PKD1/PKD2), composed of products of genes responsible for autosomal dominant polycystic kidney disease (ADPKD), depends on cholesterol.

Key findings: The L517R variant and model-specific responses to supplementation

The researchers focused on the ADPKD-associated amino acid substitution p.L517R in a cholesterol-binding site of polycystin-2 (PKD2). Mice carrying this variant showed ciliopathy-associated phenotypes, including polycystic kidneys and situs inversus, in which the left-right positions of internal organs are reversed.

The L517R variant protein showed reduced ciliary localization despite normal ion-channel activity. This indicates that channel activity and protein localization within cilia should be assessed separately. The abstract reports reduced localization; it does not establish complete blockage of ciliary entry or sequestration within the cell. Nor can it be interpreted as directly demonstrating the entire pathway from loss of stimulus sensing in kidney cells to cyst formation.

Responses to cholesterol supplementation also differed by model. In Zellweger syndrome model cells with impaired peroxisome biogenesis, supplementation with exogenous cholesterol corrected the PKD2 ciliary transport defect and reversed the dilation of epithelial luminal structures. The same recovery was not observed in L517R mutant cells. This comparison provides a basis for distinguishing impaired cholesterol supply from a mutation in the PKD2 binding site. These observations were made in model cells and do not represent an assessment of treatment effects in patients.

Implications and outlook: A potential target and questions for validation

The review authors interpret PKD2’s ability to bind directly to ciliary membrane cholesterol as an important element of ADPKD-related mechanisms. The finding that ciliary localization can be impaired even when channel activity is preserved suggests that assessments of protein function should also consider protein location and the membrane’s lipid environment.

However, the available material is the review abstract. The number of animals, cell types, cholesterol supplementation concentration and duration, percentage reduction in localization, and magnitude of structural recovery in the earlier experiments have not been confirmed. The supplied abstract also provides no quantitative data establishing that cholesterol-binding ability was completely lost. The value of ciliary membrane cholesterol as a therapeutic target remains a question for further validation; these findings alone do not support recommending cholesterol supplementation or genotype-based treatment selection for patients.

Source: Review citation and abstract, DOI: 10.1254/fpj.25078.